Recent breakthroughs in understanding the prostaglandin D2 (PGD2) receptor 1 (DP1) are paving the way for innovative ...

The engineered RSV G protein, with the RSV G antigen in orange and the human antibody in grey. Close interactions with infectious disease set both UC Santa Cruz graduate student Ana Nuñez Castrejon ...

High levels of maternally derived RSV-neutralizing antibodies correlate with a decreased risk of infection and hospitalization in newborn infants. G protein is a 90-kDa, highly glycosylated ...

More information: Michael G Ison et al, Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over ...

But many don’t deliver the benefits you might expect. Even some of the ones with health claims like “high in protein” are nothing more than glorified candy bars, says Natalie Allen ...

Second, anti-RSV G protein titers in neonatal blood samples peaked at birth but showed a marked decline by two months of age. Vaccination-derived antibodies persisted longer and at higher ...

Protein-based vaccines include subunits, such as RSV preF protein or glycoprotein (G) as single antigens and particle-based vaccines that might achieve increased immunogenicity by displaying multiple ...

The RSV attachment protein (G) has been shown to be critical in invading airway epithelial cells through its CX3C motif interacting with the host receptor CX3CR1. The ubiquitous expression of this ...

The antibody attaches on to the F protein in RSV, which prevents the virus from attaching to other cells and entering them. The antibody is called immunoglobulin G (IgG), and it’s common in our ...